Quotes 5-day view Delayed Nyse
05/16/2022
05/17/2022
05/18/2022
05/19/2022
05/20/2022
Date
95.93(c)
97.39(c)
93.41(c)
94.37(c)
94.32
Last
2 385 156
2 269 599
2 155 679
2 407 047
2 956 632
Volume
-1.66%
+1.52%
-4.09%
+1.03%
-0.05%
Change
Estimated financial data (e) (USD)
Sales 2022
5 734 M
-
-
Net income 2022
1 558 M
-
-
Net cash position 2022
1 316 M
-
-
P/E ratio 2022
38,2x
Yield 2022
-
Sales 2023
6 412 M
-
-
Net income 2023
1 724 M
-
-
Net cash position 2023
2 470 M
-
-
P/E ratio 2023
34,6x
Yield 2023
-
Capitalization
58 675 M
58 675 M
-
EV / Sales 2022
10,0x
EV / Sales 2023
8,77x
Nbr of Employees
15 700
Free-Float
96,5%
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- hemodynamic monitoring systems (67%);
- heart valves and surgery products (17%);
- other (16%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United...
Ratings of Edwards Lifesciences Corporation
All news about EDWARDS LIFESCIENCES CORPORATION
News in other languages on EDWARDS LIFESCIENCES CORPORATION
Analyst Recommendations on EDWARDS LIFESCIENCES CORPORATION
Chart EDWARDS LIFESCIENCES CORPORATION
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends EDWARDS LIFESCIENCES CORPORATION
Short Term Mid-Term Long Term Trends Bearish Bearish Bearish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
BUY
Number of Analysts
24
Last Close Price
94,37 $
Average target price
125,90 $
Spread / Average Target
33,4%
Please enable JavaScript in your browser's settings to use dynamic charts.